Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Leibowitz

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Design and synthesis of benzofused heterocyclic RXR modulatorsD L Gernert, D A Neel, M F Boehm, et al.
Diabetes|January 1, 1995
A novel insulin secretagogue is a phosphodiesterase inhibitorM D Leibowitz, C Biswas, E J Brady, et al.
The Journal of Experimental Medicine|April 3, 2001
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategiesP Desreumaux, L Dubuquoy, S Nutten, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Design, synthesis and structure-activity relationship of novel RXR-selective modulatorsPierre-Yves Michellys, Jennifer D'Arrigo, Timothy A Grese, et al.
Molecular and Cellular Endocrinology|June 16, 2000
A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleusJ Berger, H V Patel, J Woods, et al.
Molecular Endocrinology (Baltimore, Md.)|December 25, 2008
Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in cultureRachid Safi, Garrett G Muramoto, Alice B Salter, et al.
The Journal of Biological Chemistry|April 10, 2004
Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesisHeidi R Kast-Woelbern, Sharon L Dana, Rosemary M Cesario, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptorT Claudel, M D Leibowitz, C Fiévet, et al.
BMC Cancer|June 1, 2022
Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohortBenjamin D Leibowitz, Bonnie V Dougherty, Joshua S K Bell, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Design and synthesis of benzofused heterocyclic RXR modulatorsD L Gernert, D A Neel, M F Boehm, et al.
Diabetes|January 1, 1995
A novel insulin secretagogue is a phosphodiesterase inhibitorM D Leibowitz, C Biswas, E J Brady, et al.
The Journal of Experimental Medicine|April 3, 2001
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategiesP Desreumaux, L Dubuquoy, S Nutten, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Design, synthesis and structure-activity relationship of novel RXR-selective modulatorsPierre-Yves Michellys, Jennifer D'Arrigo, Timothy A Grese, et al.
Molecular and Cellular Endocrinology|June 16, 2000
A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleusJ Berger, H V Patel, J Woods, et al.
Molecular Endocrinology (Baltimore, Md.)|December 25, 2008
Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in cultureRachid Safi, Garrett G Muramoto, Alice B Salter, et al.
The Journal of Biological Chemistry|April 10, 2004
Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesisHeidi R Kast-Woelbern, Sharon L Dana, Rosemary M Cesario, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptorT Claudel, M D Leibowitz, C Fiévet, et al.
BMC Cancer|June 1, 2022
Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohortBenjamin D Leibowitz, Bonnie V Dougherty, Joshua S K Bell, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
Pageof 10